“…MIAVR-RT was developed in the past few years [2]; its use is not widespread because of the limited exposure of shown advantages of the minimally invasive approach in terms of decreased bleeding, postsurgical pain and trauma, and shorter hospital and intensive care unit stay times, with consequent costs reduction [17][18][19]. An additional issue is whether peripheral cannulation is needed.…”